Two hundred and eighty targets were upregulated or downregulated in 14 cancer types, among which BAX, CENPK, DLL3, and NOTCH3 showed a consistent upregulation in multiple cancers and glioma, indicating that these genes may play a carcinogenic role in a variety of cancers. This evidence concerns the gene DLL3 and cancer.